Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective?
AUTOR(ES)
Cossu, Giulio
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=378519Documentos Relacionados
- Inflammatory myopathies: an update for neurologists
- Editorial: Wishful thinking
- Spirometric screening for COPD: wishful thinking, not evidence
- High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.
- Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series